Investing.com - Valeo (EPA:VLOF) Pharma reported on Tuesday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Valeo Pharma announced earnings per share of C$-0.055 on revenue of C$6.1M. Analysts polled by Investing.com anticipated EPS of C$-0.055 on revenue of C$6M.
Valeo Pharma shares are down 23.13% from the beginning of the year, still down 40.21% from its 52 week high of C$0.97 set on October 7, 2021.
Valeo Pharma follows other major Healthcare sector earnings this month
Valeo Pharma's report follows an earnings missed by Cresco Labs on August 17, who reported EPS of C$-0.02 on revenue of C$218.23M, compared to forecasts EPS of C$-0.0161 on revenue of C$218.27M.
Jushi Holdings had missed expectations on August 29 with second quarter EPS of C$-0.15 on revenue of C$72.8M, compared to forecast for EPS of C$-0.0932 on revenue of C$69.15M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar